MAM
Content discovery platform Outbrain appoints Zirca as sales partner in India
MUMBAI: Outbrain, the global content discovery platform, has entered into a sales partnership in India with Zirca – a digital brand solutions and media representation company.
The partnership will help Outbrain strengthen its presence and build a solid foundation for the company to further penetrate the region.
“India is one of Outbrain’s fastest growing markets and we’ve seen tremendous response from marketers using our technology to amplify their content. Zirca has a team of over 20 digital experts working with brands across India, and we look forward to working with them to help more marketers amplify their content,” said Outbrain general manager, SEA and India Gulshan Verma.
Zirca Digital Solutions director Neena Dasgupta added, “We’re incredibly excited about the potential of this new partnership. Outbrain’s superb reputation is entirely in sync with the reputation that Zirca has worked so hard to create in India. Zirca works with many of the top 100 marketers in India and we look forward to bringing them Outbrain’s unique amplify solutions.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
